SCN1A and schizophrenia: Previous studies have shown that miR‐137 is implicated in various brain diseases, including autism spectrum disorder,[49] schizophrenia,[50] intellectual disability,[51] and drug withdrawal.[52] Thus, further studies should explore the roles of miR‐137 in human brain diseases regarding the sodium channel subunit NaV1.1.